MetLife Investment Advisors »

Genes shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Genes (GCO) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $189k 6.9k 27.17
2024-06-30 $180k 6.9k 25.86
2023-12-31 $221k 6.3k 35.21
2023-09-30 $193k 6.3k 30.82
2023-06-30 $157k 6.3k 25.04
2023-03-31 $231k 6.3k 36.88
2022-12-31 $336k 7.3k 46.02
2022-09-30 $307k 7.8k 39.32
2022-06-30 $390k 7.8k 49.91
2022-03-31 $497k 7.8k 63.61
2021-12-31 $320k 5.0k 64.17
2021-09-30 $288k 5.0k 57.73
2021-06-30 $405k 6.4k 63.68
2021-03-31 $302k 6.4k 47.50
2020-12-31 $191k 6.4k 30.09
2020-09-30 $137k 6.4k 21.54
2020-06-30 $138k 6.4k 21.66
2020-03-31 $85k 6.4k 13.37
2019-12-31 $305k 6.4k 47.92
2019-09-30 $254k 6.4k 40.02
2019-06-30 $367k 8.7k 42.29
2019-03-31 $396k 8.7k 45.55
2018-12-31 $385k 8.7k 44.30
2018-09-30 $655k 14k 47.10
2018-06-30 $345k 8.7k 39.73
2018-03-31 $353k 8.7k 40.65
2017-12-31 $282k 8.7k 32.48